HomeNewsNeuroscience

  • Positive Ph 1 data for Xenon’s Anti-Epileptic drug presented at Eilat Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • PM20D1 gene associated with Alzheimer’s disease incidence, research finds

    • May 15, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Briviact approved by FDA for partial-onset seizures in pediatric epilepsy patients

    • May 15, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New App can improve Epilepsy diagnosis

    • May 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Gilenya approved by FDA for Pediatric RMS patients

    • May 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • First Parkinson’s patient treated with Insightec’s Incisionless Brain Surgery

    • May 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spinal fluid can predict MS progression, claims study

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New epilepsy drugs could be derived from Red Sea fungus, new study finds

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • 33 percent more people suffer from Depression as compared to 2013, new research finds

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Molecule could reduce Alzheimer’s degradation, study finds

    • May 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more